Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL130434 | 1.00 | LMNA (0.64) | LMNATDP1TSHRMAPK1SLC6A2 | |
| SCHEMBL1771682 | 1.00 | LMNA (0.64) | LMNATDP1TSHRMAPK1SLC6A2 | |
| Benzoic Acid SCHEMBL1864558 | 0.95 | LMNA (0.58) | LMNATDP1TSHRMAPK1SLC6A2 | |
| (Z)-Hex-3-En-1-Yl Acetate SCHEMBL28969715 | 0.94 | LMNA (0.57) | LMNATDP1TSHRMAPK1SLC6A2 | |
| SCHEMBL30285512 | 0.90 | LMNA (0.69) | LMNATDP1TSHRMAPK1SLC6A2 | |
| SCHEMBL3751591 | 0.89 | TDP1 (0.67) | LMNATDP1TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL3751588 | 0.89 | TDP1 (0.67) | LMNATDP1TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL27491796 | 0.88 | TDP1 (0.65) | LMNATDP1TSHRMAPK1KMT2A | |
| Ethyl Benzoate SCHEMBL29361886 | 0.86 | LMNA (0.48) | LMNATDP1TSHRMAPK1KMT2A | |
| SCHEMBL30853560 | 0.85 | LMNA (0.48) | LMNATDP1TSHRMAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 540 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4581114-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Novozymes A/S (DK) | 2025-07-09 | — | — | EP | claimed |
| US-20250129312-A1 | CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2025-04-24 | — | — | US | claimed |
| US-12209232-B2 | Consumer product compositions with perfume encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2025-01-28 | — | — | US | claimed |
| EP-3689849-B1 | PERFUME PRECURSOR | TAKASAGO PERFUMERY CO LTD (JP) | 2025-01-15 | — | — | EP | claimed |
| WO-2024213536-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| US-20240306688-A1 | METHOD OF MITIGATING OFF-ODORS | GIVAUDAN SA (CH) | 2024-09-19 | — | — | US | claimed |
| EP-4391827-A1 | METHOD OF MITIGATING OFF-ODORS | Givaudan SA (CH) | 2024-07-03 | — | — | EP | claimed |
| WO-2024046952-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | NOVOZYMES A/S (DK) | 2024-03-07 | — | — | WO | claimed |
| EP-2512406-A1 | PERFUMES AND PERFUME ENCAPSULATES | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | claimed |
| WO-2011075556-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | claimed |
| WO-2011075551-A1 | PERFUMES AND PERFUME ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | claimed |
| US-20110020516-A1 | JASMINUM SAMBAC-LIKE FRAGRANCE COMPOSITION | SHISEIDO COMPANY LTD. (JP) | 2011-01-27 | — | — | US | claimed |
| US-20100247475-A1 | BETA-GLUCURONIDASE INHIBITOR | KAO CORPORATION (JP) | 2010-09-30 | — | — | US | claimed |
| EP-2196525-A1 | JASMINUM SAMBAC-LIKE FRAGRANCE COMPOSITION | Shiseido Company, Ltd. (JP) | 2010-06-16 | — | — | EP | claimed |
| EP-2192178-A1 | B-GLUCURONIDASE INHIBITOR | Kao Corporation (JP) | 2010-06-02 | — | — | EP | claimed |
| US-4151309-A | FOODS, CHEWING GUM, DENTIFRICES, DRUGS | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1979-04-24 | — | — | US | claimed |
| US-4136208-A | FLAVORING WITH SUBSTITUTED NORBORNANE DERIVATIVES | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1979-01-23 | — | — | US | claimed |
| US-4076853-A | Flavoring with substituted norbornane derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-02-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100247475-A1 | BETA-GLUCURONIDASE INHIBITOR | GUSB, GAA, GANAB | LMNA 3810/4885TDP1 3333/4885TSHR 3938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.